Detalhe da pesquisa
1.
Plasma neurofilament light chain as a biomarker for fatal familial insomnia.
Eur J Neurol
; 29(6): 1841-1846, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212083
2.
Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease.
Mov Disord
; 36(12): 2967-2969, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553776
3.
Validation of Plasma Neurofilament Light Chain as a Marker for α-Synucleinopathies.
Mov Disord
; 36(11): 2701-2703, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379333
4.
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
Transl Neurodegener
; 12(1): 12, 2023 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915212
5.
Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease.
Alzheimers Res Ther
; 15(1): 106, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37291640
6.
Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease.
Mol Neurobiol
; 59(9): 1-9, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716271
7.
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies.
Front Aging Neurosci
; 13: 717930, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34630068
8.
Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and nonrapidly progressive Alzheimer's disease.
Alzheimers Res Ther
; 15(1): 116, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349779